Mortality and causes of death in patients with atrial fibrillation: A nationwide population-based study

• Published in: PloS one Vol. 13; no. 12; p. e0209687
• Main Authors: Lee, Euijae, Choi, Eue-Keun, Han, Kyung-Do, Lee, HyunJung, Choe, Won-Seok, Lee, So-Ryoung, Cha, Myung-Jin, Lim, Woo-Hyun, Kim, Yong-Jin, Oh, Seil
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 26.12.2018; Public Library of Science (PLoS)
• Subjects: Adult; Age; Aged; Aged, 80 and over; Anticoagulants; Atrial fibrillation; Atrial Fibrillation - mortality; Atrial Fibrillation - physiopathology; Biology and Life Sciences; Cardiac arrhythmia; Cardiovascular disease; Cardiovascular diseases; Cardiovascular Diseases - mortality; Cardiovascular Diseases - physiopathology; Cause of Death; Cerebral infarction; Cerebral Infarction - mortality; Cerebral Infarction - physiopathology; Confidence intervals; Death; Female; Fibrillation; Health risk assessment; Health risks; Humans; Infarction; Korea; Male; Medicine and Health Sciences; Men; Middle Aged; Mortality; Neoplasms - mortality; Neoplasms - physiopathology; Patient outcomes; Patients; Population studies; Population-based studies; Prognosis; Registries; Risk; Risk Assessment; Risk Factors; Risk reduction; South Korea; Stroke; Stroke - mortality; Stroke - physiopathology; Studies; Young Adult; Korea; South Korea; Asia; United States > US
• ISSN: 1932-6203; 1932-6203
• DOI: 10.1371/journal.pone.0209687

Patients with atrial fibrillation are known to have a high risk of mortality. There is a paucity of population-based studies about the impact of atrial fibrillation on the mortality risk stratified by age, sex, and detailed causes of death. A total of 15,411 patients with atrial fibrillation from the Korean National Health Insurance Service-National Sample Cohort were enrolled, and causes of death were identified according to codes of the 10th revision of the International Classification of Diseases. From 2002 to 2013, a total of 4,479 (29%) deaths were confirmed, and the crude mortality rate for all-cause death was 63.3 per 1,000 patient-years. Patients with atrial fibrillation had a 3.7-fold increased risk of all-cause death compared with the general population. The standardized mortality ratio for all-cause death was the highest in young patients and decreased with increasing age (standardized mortality ratio 21.93, 95% confidence interval 7.60-26.26 in patients aged <20 years; standardized mortality ratio 2.77, 95% confidence interval 2.63-2.91 in patients aged ≥80 years). Women with atrial fibrillation exhibited a greater excess mortality risk than men (standardized mortality ratio 3.81, 95% confidence interval 3.65-3.98 in women; standardized mortality ratio 3.35, 95% confidence interval 3.21-3.48 in men). Cardiovascular disease was the leading cause of death (38.5%), and cerebral infarction was the most common specific disease. Patients with atrial fibrillation had an about 5 times increased risk of death due to cardiovascular disease compared with the general population. Patients with atrial fibrillation had a 4 times increased risk of mortality compared with the general population. However, the impact of atrial fibrillation on mortality decreased with age and in men. Cerebral infarction was the most common cause of death, and more attention should be paid to reducing the risk of stroke.